Article

Transitions pursues new communications platforms

Promoting lenses directly to consumers is just one channel of an innovative digital outreach program from Transitions Optical.

Pinellas Park, FL-Promoting lenses directly to consumers is just one channel of an innovative digital outreach program from Transitions Optical. The new message in a new medium is designed to urge patients to find out more about the technology by driving consumers to the Transitions Web site.

Transitions is offering interactive experiences for online users through advertisements on many popular Web sites. For example, streaming video at http://www.ABC.com/ enables users to learn more about the nature photojournalists featured in current Transitions print ads. According to the company, during the next 2 months, an estimated 477,000 viewers of streaming video will hear more about why the photographers' eyewear of choice includes the new Transitions lenses. Online spots and branding on the Golf Channel Web site will serve to remind viewers of the recently announced PGA TOUR sponsorship. Transitions also has placed digital outreach on additional sites such as Dynamic Logic, MSN, Reuters, Search, WebMD, and Yahoo!

The overall initiative of educating consumers about the importance of healthy sight will make an estimated 67 million impressions, according to the company.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.